Specifications TableSubjectChemistrySpecific subject areaNatural products researchType of dataFigureHow data were acquiredFirst, the compounds were isolated from the 70% ethanol-water extract of *P. cornutum* roots. Then the samples were dissolved in DMSO‑*d*~6~ or CD~3~OD before NMR test.Data formatRaw and AnalyzedParameters for data collectionThe NMR spectra data parameters including chemical shift *δ*-values and coupling constant (*J*). The MS spectra data parameters including *m/z*.Description of data collectionNMR spectra data of novel compounds from the roots of *P. cornutum* were recorded on a Bruker Advance-500 spectrometer using standard Bruker pulse programs (Bruker, Karlsruhe, Germany). Chemical shifts were shown as *δ*-values with reference to tetramethylsilane (TMS) as an internal standard. Positive- and negative-ion HRESI-TOF-MS of novel compounds from *P. cornutum* roots were recorded on an Agilent Technologies 6520 Accurate-Mass Q-Tof LC/MS spectrometer.Data source locationTianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, ChinaData accessibilityData is with the article \[[@bib1]\]Related research articleW. Shi, J. Ruan, Y. Guo, Z. Ding, J. Yan, L. Qu, C. Zheng, Y. Zhang, T. Wang, Bioactive constituents study of Pugionium cornutum L. Gaertn on intestinal motility, Fitoerapia, 138 (2019) 104291.**Value of the Data**•NMR and MS data of novel compounds is important for elucidating their chemical structures.•NMR and MS data of novel thiohydantoin derivatives is useful for the elucidating their chemical analogues.•This information will allow comparisons across different thiohydantoin derivatives and other new compounds from *Pugionium* species or Cruciferae family plant sources.

1. Data {#sec1}
=======

The dataset contains raw analysis data obtained through the chemistry research of the dried roots of Mongolian medicinal and edible plant, *Pugionium cornutum* L. Gaertn. Information about the eight new compounds pugcornols A (**1**), B (**2**), C (**3**), and D (**4**), pugcornosides A (**5**), B (**6**), C (**7**), and D (**8**) has been presented in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"}, [Fig. 10](#fig10){ref-type="fig"}, [Fig. 11](#fig11){ref-type="fig"}, [Fig. 12](#fig12){ref-type="fig"}, [Fig. 13](#fig13){ref-type="fig"}, [Fig. 14](#fig14){ref-type="fig"}, [Fig. 15](#fig15){ref-type="fig"}, [Fig. 16](#fig16){ref-type="fig"}, [Fig. 17](#fig17){ref-type="fig"}, [Fig. 18](#fig18){ref-type="fig"}, [Fig. 19](#fig19){ref-type="fig"}, [Fig. 20](#fig20){ref-type="fig"}, [Fig. 21](#fig21){ref-type="fig"}, [Fig. 22](#fig22){ref-type="fig"}, [Fig. 23](#fig23){ref-type="fig"}, [Fig. 24](#fig24){ref-type="fig"}, [Fig. 25](#fig25){ref-type="fig"}, [Fig. 26](#fig26){ref-type="fig"}, [Fig. 27](#fig27){ref-type="fig"}, [Fig. 28](#fig28){ref-type="fig"}, [Fig. 29](#fig29){ref-type="fig"}, [Fig. 30](#fig30){ref-type="fig"}, [Fig. 31](#fig31){ref-type="fig"}, [Fig. 32](#fig32){ref-type="fig"}, [Fig. 33](#fig33){ref-type="fig"}, [Fig. 34](#fig34){ref-type="fig"}, [Fig. 35](#fig35){ref-type="fig"}, [Fig. 36](#fig36){ref-type="fig"}, [Fig. 37](#fig37){ref-type="fig"}, [Fig. 38](#fig38){ref-type="fig"}, [Fig. 39](#fig39){ref-type="fig"}, [Fig. 40](#fig40){ref-type="fig"}, [Fig. 41](#fig41){ref-type="fig"}, [Fig. 42](#fig42){ref-type="fig"}, [Fig. 43](#fig43){ref-type="fig"}, [Fig. 44](#fig44){ref-type="fig"}, [Fig. 45](#fig45){ref-type="fig"}.Fig. 1^1^H NMR (500 MHz, DMSO‑*d*~6~) spectrum of compound **1**.Fig. 1Fig. 2^13^C NMR (125 MHz, DMSO‑*d*~6~) spectrum of compound **1**.Fig. 2Fig. 3DEPT 135 (DMSO‑*d*~6~) spectrum of compound **1**.Fig. 3Fig. 4^1^H ^1^H COSY (DMSO‑*d*~6~) spectrum of compound **1**.Fig. 4Fig. 5HSQC (DMSO‑*d*~6~) spectrum of compound **1**.Fig. 5Fig. 6HMBC (DMSO‑*d*~6~) spectrum of compound **1**.Fig. 6Fig. 7HRESI-TOF-MS spectrum of compound **1**.Fig. 7Fig. 8^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **2**.Fig. 8Fig. 9^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **2**.Fig. 9Fig. 10DEPT 135 (CD~3~OD) spectrum of compound **2**.Fig. 10Fig. 11^1^H ^1^H COSY (CD~3~OD) spectrum of compound **2**.Fig. 11Fig. 12HSQC (CD~3~OD) spectrum of compound **2**.Fig. 12Fig. 13HMBC (CD~3~OD) spectrum of compound **2**.Fig. 13Fig. 14HRESI-TOF-MS spectrum of compound **2**.Fig. 14Fig. 15^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **3**.Fig. 15Fig. 16^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **3**.Fig. 16Fig. 17DEPT 135 (CD~3~OD) spectrum of compound **3**.Fig. 17Fig. 18^1^H ^1^H COSY (CD~3~OD) spectrum of compound **3**.Fig. 18Fig. 19HSQC (CD~3~OD) spectrum of compound **3**.Fig. 19Fig. 20HMBC (CD~3~OD) spectrum of compound **3**.Fig. 20Fig. 21HRESI-TOF-MS spectrum of compound **3**.Fig. 21Fig. 22^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **4**.Fig. 22Fig. 23^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **4**.Fig. 23Fig. 24DEPT 135 (CD~3~OD) spectrum of compound **4**.Fig. 24Fig. 25^1^H ^1^H COSY (CD~3~OD) spectrum of compound **4**.Fig. 25Fig. 26HSQC (CD~3~OD) spectrum of compound **4**.Fig. 26Fig. 27HMBC (CD~3~OD) spectrum of compound **4**.Fig. 27Fig. 28HRESI-TOF-MS spectrum of compound **4**.Fig. 28Fig. 29^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **5**.Fig. 29Fig. 30^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **5**.Fig. 30Fig. 31DEPT 135 (CD~3~OD) spectrum of compound **5**.Fig. 31Fig. 32^1^H ^1^H COSY (CD~3~OD) spectrum of compound **5**.Fig. 32Fig. 33HSQC (CD~3~OD) spectrum of compound **5**.Fig. 33Fig. 34HMBC (CD~3~OD) spectrum of compound **5**.Fig. 34Fig. 35HRESI-TOF-MS spectrum of compound **5**.Fig. 35Fig. 36^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **6**.Fig. 36Fig. 37^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **6**.Fig. 37Fig. 38DEPT 135 (CD~3~OD) spectrum of compound **6**.Fig. 38Fig. 39^1^H ^1^H COSY (CD~3~OD) spectrum of compound **6**.Fig. 39Fig. 40HSQC (CD~3~OD) spectrum of compound **6**.Fig. 40Fig. 41HMBC (CD~3~OD) spectrum of compound **6**.Fig. 41Fig. 42HRESI-TOF-MS spectrum of compound **6**.Fig. 42Fig. 43^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **7**.Fig. 43Fig. 44^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **7**.Fig. 44Fig. 45DEPT 135 (CD~3~OD) spectrum of compound **7**.Fig. 45Fig. 46^1^H ^1^H COSY (CD~3~OD) spectrum of compound **7**.Fig. 46Fig. 47HSQC (CD~3~OD) spectrum of compound **7**.Fig. 47Fig. 48HMBC (CD~3~OD) spectrum of compound **7**.Fig. 48Fig. 49HRESI-TOF-MS spectrum of compound **7**.Fig. 49Fig. 50^1^H NMR (500 MHz, CD~3~OD) spectrum of compound **8**.Fig. 50Fig. 51^13^C NMR (125 MHz, CD~3~OD) spectrum of compound **8**.Fig. 51Fig. 52DEPT 135 (CD~3~OD) spectrum of compound **8**.Fig. 52Fig. 53^1^H ^1^H COSY (CD~3~OD) spectrum of compound **8**.Fig. 53Fig. 54HSQC (CD~3~OD) spectrum of compound **8**.Fig. 54Fig. 55HMBC (CD~3~OD) spectrum of compound **8**.Fig. 55Fig. 56HRESI-TOF-MS spectrum of compound **8**.Fig. 56

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Study area description {#sec2.1}
---------------------------

*Pugionium cornutum* L. Gaertn (PC), Cruciferae family, is widely distributed in the Badain Jaran Desert, Kubuqi Desert, Mu Us Desert, Horqin sandy land, and Hulunbuir sandy land \[[@bib2]\]. As the traditional arenicolous Mongolian medicine, PC has accumulated rich experience and knowledge of promoting gastrointestinal motility and improving indigestion \[[@bib3]\]. Previously, a further phytochemical investigation on the 70% ethanol-water extract of the roots of *P. cornutum* led to the isolation and characterization of eight compounds that have been not reported previously. Among them, **1**--**4** were rare naturally occurring thiohydantoin derivatives. Herein, their structure characterization has been identified by various spectrometry methods including NMR and MS spectra.

2.2. Plant material {#sec2.2}
-------------------

The roots of *Pugionium cornutum* L. Gaertn were collected from Alxa Youqi, Inner Mongolia Autonomous region, China, and identified by Dr. Li Tianxiang (Experiment Teaching Department, Tianjin University of Traditional Chinese Medicine). The voucher specimen was deposited at the Academy of Traditional Chinese Medicine of Tianjin University of TCM.

2.3. NMR and MS spectrum of the isolates {#sec2.3}
----------------------------------------

The dried roots of PC were refluxed with 70% ethanol-water for three times. Evaporation of the solvent under pressure provided a 70% ethanol-water extract, which was partitioned with H~2~O and EtOAc to gain H~2~O layer and EtOAc layer partition, respectively. The H~2~O layer partition was subjected to D101 macroporous resin CC and eluted with H~2~O, 95% EtOH, and acetone, successively. Then 95% EtOH eluate and EtOAc layer partition was isolated by silica gel, Sephadex LH-20 chromatography columns and preparative HPLC. As results, four new rare thiohydantoin derivatives pugcornols A (**1**), B (**2**), C (**3**), and D (**4**) \[[@bib4], [@bib5], [@bib6], [@bib7]\], two new glucosinolates pugcornosides A (**5**) \[[@bib8], [@bib9], [@bib10]\], B (**6**) \[[@bib10]\], two new others pugcornosides C (**7**) \[[@bib11]\], D (**8**) were obtained and identified by using NMR, MS, ECD technologies, as well as chemical reaction.

### 2.3.1. Pugcornol A (**1**) {#sec2.3.1}

Colorless oil; \[*α*\]~D~^25^ --31.3 (*conc.* 0.12, MeOH); CD (*conc*. 0.0015 M, MeOH) mdeg (*λ*~nm~): --1.39 (235), −3.33 (256), −3.60 (269); CD (*conc*. 0.0015 M, CH~3~CN) mdeg (*λ*~nm~): --1.21 (229), −2.83 (245), −4.52 (267); UV *λ*~max~ (MeOH) nm (log *ε*): 269 (3.81); IR *ν*~max~ (KBr) cm^−1^: 3364, 2943, 1750, 1424, 1347, 1225, 1124, 1061, 1025; ^1^H NMR (DMSO‑*d*~6~, 500 MHz) and ^13^C NMR (DMSO‑*d*~6~, 125 MHz) data see [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 7](#fig7){ref-type="fig"}.

### 2.3.2. Pugcornol B (**2**) {#sec2.3.2}

Colorless oil; \[*α*\]~D~^25^ --39.3 (*conc.* 0.12, MeOH); CD (*conc*. 0.0015 M, MeOH) mdeg (*λ*~nm~): --1.30 (223), −5.34 (270); CD (*conc*. 0.0015 M, CH~3~CN) mdeg (*λ*~nm~): --1.56 (223), −6.80 (252), −4.81 (272); UV *λ*~max~ (MeOH) nm (log *ε*): 277 (3.96); IR *ν*~max~ (KBr) cm^−1^: 3355, 2941, 1750, 1428, 1346, 1236, 1133, 1049, 1010; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"}, [Fig. 10](#fig10){ref-type="fig"}, [Fig. 11](#fig11){ref-type="fig"}, [Fig. 12](#fig12){ref-type="fig"}, [Fig. 13](#fig13){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 14](#fig14){ref-type="fig"}.

### 2.3.3. Pugcornol C (**3**) {#sec2.3.3}

Colorless oil; \[*α*\]~D~^25^ --36.1 (*conc.* 0.14, MeOH); CD (*conc*. 0.0015 M, MeOH) mdeg (*λ*~nm~): --0.34 (228), −2.60 (253), −2.99 (269); CD (*conc*. 0.0015 M, CH~3~CN) mdeg (*λ*~nm~): --1.26 (231), −3.91 (250), −5.16 (267); UV *λ*~max~ (MeOH) nm (log *ε*): 249 (3.50), 268 (3.58); IR *ν*~max~ (KBr) cm^−1^: 3365, 2935, 1749, 1419, 1347, 1236, 1133, 1050, 1015; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 14](#fig14){ref-type="fig"}, [Fig. 15](#fig15){ref-type="fig"}, [Fig. 16](#fig16){ref-type="fig"}, [Fig. 17](#fig17){ref-type="fig"}, [Fig. 18](#fig18){ref-type="fig"}, [Fig. 19](#fig19){ref-type="fig"}, [Fig. 20](#fig20){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 21](#fig21){ref-type="fig"}.

### 2.3.4. Pugcornol D (**4**) {#sec2.3.4}

Colorless oil; \[*α*\]~D~^25^ --64.1 (*conc*. 0.13, MeOH); CD (*conc*. 0.0015 M, MeOH) mdeg (*λ*~nm~): --35.54 (214), +14.06 (238), +0.12 (263); CD (*conc*. 0.0015 M, CH~3~CN) mdeg (*λ*~nm~): --33.13 (212), 12.47 (238), +0.23 (262); UV *λ*~max~ (MeOH) nm (log *ε*): 214 (3.44), 267 (2.38); IR *ν*~max~ (KBr) cm^−1^: 3420, 2943, 1765, 1701, 1447, 1419, 1361, 1014; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 22](#fig22){ref-type="fig"}, [Fig. 23](#fig23){ref-type="fig"}, [Fig. 24](#fig24){ref-type="fig"}, [Fig. 25](#fig25){ref-type="fig"}, [Fig. 26](#fig26){ref-type="fig"}, [Fig. 27](#fig27){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 28](#fig28){ref-type="fig"}.

### 2.3.5. Pugcornoside A (**5**) {#sec2.3.5}

White powder; \[*α*\]~D~^25^ --23.2 (*conc.* 0.11, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 223 (3.61), 277 (3.18); IR *ν*~max~ (KBr) cm^−1^: 3365, 2922, 1646, 1558, 1507, 1457, 1277, 1070; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 29](#fig29){ref-type="fig"}, [Fig. 30](#fig30){ref-type="fig"}, [Fig. 31](#fig31){ref-type="fig"}, [Fig. 32](#fig32){ref-type="fig"}, [Fig. 33](#fig33){ref-type="fig"}, [Fig. 34](#fig34){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 35](#fig35){ref-type="fig"}.

### 2.3.6. Pugcornoside B (**6**) {#sec2.3.6}

White powder; \[*α*\]~D~^25^ --52.6 (*conc.* 0.13, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 220 (3.65), 277 (3.18); IR *ν*~max~ (KBr) cm^−1^: 3366, 2918, 1600, 1507, 1456, 1436, 1278, 1045, 1072; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 36](#fig36){ref-type="fig"}, [Fig. 37](#fig37){ref-type="fig"}, [Fig. 38](#fig38){ref-type="fig"}, [Fig. 39](#fig39){ref-type="fig"}, [Fig. 40](#fig40){ref-type="fig"}, [Fig. 41](#fig41){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 42](#fig42){ref-type="fig"}.

### 2.3.7. Pugcornoside C (**7**) {#sec2.3.7}

White powder; \[*α*\]~D~^25^ +6.3 (*conc*. 0.12,MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 266 (2.94); IR *ν*~max~ (KBr) cm^−1^: 3386, 2391, 1734, 1652, 1107, 1044; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 43](#fig43){ref-type="fig"}, [Fig. 44](#fig44){ref-type="fig"}, [Fig. 45](#fig45){ref-type="fig"}, [Fig. 46](#fig46){ref-type="fig"}, [Fig. 47](#fig47){ref-type="fig"}, [Fig. 48](#fig48){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 49](#fig49){ref-type="fig"}.

### 2.3.8. Pugcornoside D (**8**) {#sec2.3.8}

White powder; \[*α*\]~D~^25^ +28.1 (*conc*. 0.12, MeOH); UV *λ*~max~ (MeOH) nm (log *ε*): 205 (3.72), 262 (2.77); IR *ν*~max~ (KBr) cm^−1^: 3420, 2933, 1733, 1635, 1466, 1339, 1267, 1154, 1112, 1047; ^1^H NMR (CD~3~OD, 500 MHz) and ^13^C NMR (CD~3~OD, 125 MHz) data [Fig. 50](#fig50){ref-type="fig"}, [Fig. 51](#fig51){ref-type="fig"}, [Fig. 52](#fig52){ref-type="fig"}, [Fig. 53](#fig53){ref-type="fig"}, [Fig. 54](#fig54){ref-type="fig"}, [Fig. 55](#fig55){ref-type="fig"}. HRESI-TOF-MS data see [Fig. 56](#fig56){ref-type="fig"}.
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